Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT00407381

Completed

The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study

Diabetic Macular Edema
NCT00182221

Completed

Safety of a Diagnostic Strategy With D-Dimer Testing for PE

Venous Thromboembolism
NCT01968616

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO
NCT00413036

Completed

A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's
NCT02067013

Unknown

Analysis of Aqueous and Vitreous Humor (ARK)

Macular Degeneration | Proliferative Diabetic Retinopathy | Neovascular Glaucoma | Macular Hole
NCT02104323

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Endostatin)

Neurofibromatosis Type 2 | Vestibular Schwannoma
NCT03037970

Unknown

Evaluation of ABSOLVE in Diabetic Foot Ulcers (ABSOLVE)

Diabetic Foot Ulcers
NCT00966277

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Pancreatic Cancer | Venous Thromboembolism
NCT00879827

Completed

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis
NCT00538538

Withdrawn

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Macular Degeneration | Retinal Hemorrhage
NCT02596958

Completed

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

Non-Squamous Non-Small Cell Lung Cancer
NCT02652234

Unknown

Study of Endostar Subcutaneous Injection in NSCLC

NSCLC
NCT02651168

Unknown

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study

Diabetic Macular Edema
NCT00790920

Completed

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-3)

Stroke
NCT01860144

Unknown

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
NCT00407485

Completed

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Adenocarcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer
NCT00393497

Completed

A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment

Breast Cancer | Lymphedema
NCT02135770

Completed

Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis

Severe Sepsis With Septic Shock | Severe Sepsis Without Septic Shock
NCT01112085

Completed

MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) (MINIMA-2)

Diabetic Macular Edema
NCT00847639

Completed

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma (07-REV)

Multiple Myeloma
NCT00000552

Completed

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Shock, Cardiogenic
NCT00000503

Completed

Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
NCT01970202

Unknown

Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity

Obesity
NCT01232777

Withdrawn

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP) (BLOCK-ROP)

Retinopathy of Prematurity
NCT00720850

Terminated

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) (LENAMAINT)

Myelodysplastic Syndromes | Acute Myelogenous Leukemia
NCT00996931

Completed

Efficacy and Safety of Lenalidomide for Treatment of Autistic Spectrum Disorders

Autism
NCT01669447

Unknown

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

Degeneration of Macula and Posterior Pole
NCT01634438

Completed

Heparin Dose for Radial Angiography

Coronary Angiograph
NCT00564148

Completed

Intravitreal Avastin in Proliferative Retinopathies (SITE-App)

Retinal Neovascularization
NCT01260519

Completed

Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography

Diagnostic Coronary Angiography
NCT00699465

Unknown

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Intracerebral Hemorrhage
NCT01041690

Completed

Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease

Proliferative Diabetic Retinopathy
NCT01025934

Completed

Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy
NCT00051116

Completed

A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

Multiple Myeloma
NCT00854529

Unknown

Subconjunctival Bevacizumab Effect on Bleb Vascularity

Bleb Vascularity | Bleb Fibrosis | Trabeculectomy Failure
NCT00403325

Completed

Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy
NCT00370786

Completed

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Choroidal Neovascularization
NCT00656435

Completed

Bevacizumab and Long Acting Gas in Diabetic Vitrectomy

Proliferative Diabetic Retinopathy
NCT00162669

Unknown

Bevacizumab in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT00055562

Completed

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Melanoma | Neoplasm Metastasis
NCT06869291

Enrolling by invitation

Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum

Xanthelasma Palpebrarum
NCT04508036

Recruiting

Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels

Ductus Arteriosus, Patent
NCT00716820

Completed

Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

Gastrointestinal Stromal Tumors
NCT04429035

Recruiting

SLOW-Slower Progress of caLcificatiOn With Vitamin K2

Aortic Valve Stenosis | Mitral Valve Stenosis | Aortic Valve Calcification | Mitral Annular Calcification | Mitral Valve Calcification
NCT02688491

Not yet recruiting

A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

Renal Neoplasms | Targeted Molecular Therapy
NCT05083299

Completed

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

Chronic Occlusive Arterial Disease
NCT02282059

Completed

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumors
NCT02503319

Withdrawn

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015) (TRANOXY2015)

Postpartum Hemorrhage
NCT04175262

Completed

Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments

Metastatic Renal Cell Carcinoma (mRCC)
NCT01308034

Completed

Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy

Non GIST Sarcomas

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations